Bazex syndrome is a rare paraneoplastic dermatosis. The underlying malignancy frequently is squamous cell carcinoma of the upper aerodigestive tract or cervical lymph nodes from an unknown primary site. We report a 63-year-old man with squamous cell carcinoma of cervical lymph nodes from an unknown primary site. He developed a mass on the right side of his neck, cutaneous lesions diagnosed as Bazex syndrome, hypoalbuminemia, and severe ascites. Right neck dissection was performed. After neck dissection, not only the cutaneous lesions, but also the severe hypoalbuminemia and severe ascites were improved. Bazex syndrome may be associated with hypoalbuminemia and ascites.

Bazex syndrome or acrokeratosis paraneoplastica is a rare paraneoplastic dermatosis and is characterized by psoriasiform hyperkeratotic lesions [1]. In most cases, the underlying malignancy is squamous cell carcinoma of the upper aerodigestive tract or cervical lymph nodes from an unknown primary site [2]. For the cutaneous lesions, steroid and topical treatments are not effective, but treatment of the underlying tumor provides relief [3]. We here report a 63-year-old man with Bazex syndrome caused by squamous cell carcinoma of the cervical lymph nodes from an unknown primary site, who had hypoalbuminemia and severe ascites. Moreover, after surgery, not only the lesions, but also the hypoalbuminemia and ascites were improved.

A 63-year-old man with chronic hepatitis developed a neck mass and diffuse psoriasiform hyperkeratosis and bullae affecting his face, hands, and feet (fig. 1). He had no past or family history of psoriasis or other skin disease. Excisional biopsy of the neck mass was performed, and the pathological diagnosis was squamous cell carcinoma. The primary site could not be determined despite careful examination. He was diagnosed with Bazex syndrome with squamous cell carcinoma of cervical lymph nodes from an unknown primary origin and was referred to our hospital.

Fig. 1.

Left-hand with psoriasiform hyperkeratosis.

Fig. 1.

Left-hand with psoriasiform hyperkeratosis.

Close modal

On admission, his height was 165 cm, his body weight was 62 kg, his temperature was 37.5°C, his blood pressure was 132/72 mm Hg, his pulse rate was 78 beats/min, his oxygen saturation was 96% on room air, his oral intake was normal, and his serum albumin was 2.3 g/dl. Computed tomography revealed multiple masses on the right side of the neck and mild ascites. He underwent right neck dissection. Pathological examination demonstrated metastases of well-differentiated squamous cell carcinoma of level IIA and III lymph nodes, and extranodal spread was seen in the IIA lymph node. His serum albumin dropped to 1.4 g/dl by 3 days after surgery. At 10 days after surgery, he developed abdominal distension, and computed tomography revealed severe ascites (fig. 2). Ascites aspiration showed clear fluid with a specific gravity of 1.017, and a protein level of 2.0 g/dl; the Rivalta test was negative and cytology was normal.

Fig. 2.

Severe ascites as indicated by computed tomography.

Fig. 2.

Severe ascites as indicated by computed tomography.

Close modal

His ascites improved at 2 months after surgery, with improvement of his lesions. At 5 years after surgery, he had no evidence of recurrence, with the absence of ascites, and his serum albumin was 3.9 g/dl.

This case highlights two clinical important issues. Bazex syndrome can present with hypoalbuminemia and ascites, and symptoms can be improved by treatment of the underlying tumor.

Hypoalbuminemia is associated with several different diseases, including cirrhosis, burns, malnutrition, nephrotic syndrome, sepsis, and cachexia [4]. This case suffered from chronic hepatitis, but did not progress to cirrhosis. Moreover, he did not show weight loss; we therefore ruled out cachexia. In the case reported here, bullae lesions were accompanied by psoriasiform hyperkeratosis. In addition to burns, bullae of Bazex syndrome may also cause hypoalbuminemia and ascites. Bolognia et al. [2] reported that 16% of such patients developed vesicles, bullae, and crusts, in addition to psoriasiform hyperkeratosis. Additionally, Robert et al. [5] reported a patient with Bazex syndrome who developed ascites, but the association was not described.

In this case, ascites first became severe after surgery, but he improved by 2 months after surgery. This was fortunate, as we may not have opted for cancer treatment if the onset of severe ascites occurred before the treatment.

This case suggests that not only the lesions, but also hypoalbuminemia and ascites can be improved after treatment of the underlying tumor. The mechanism by which Bazex syndrome causes hypoalbuminemia and ascites has not been fully elucidated. Further investigations are necessary to ascertain this mechanism.

We obtained informed consent from the patient for publication.

The authors declare no conflict of interest.

1.
Bazex A, Griffiths A: Acrokeratosis paraneoplastica – a new cutaneous marker of malignancy. Br J Dermatol 1980;103: 301–306.
2.
Bolognia JL, Brewer YP, Cooper DL: Bazex syndrome (acrokeratosis paraneoplastica). An analytic review. Medicine 1991;70: 269–280.
3.
Sarkar B, Knecht R, Sarkar C, Weidauer H: Bazex syndrome (acrokeratosis paraneoplastica). Eur Arch Otorhinolaryngol 1998;255: 205–210.
4.
Gatta A, Verardo A, Bolognesi M: Hypoalbumia. Intern Emerg Med 2012;7(suppl):S193–S199.
5.
Robert M, Gilabert M, Rahal S, Ries P, Raoul JL: Bazex syndrome revealing a gastric cancer. Case Rep Oncol 2014; 7: 285–287.
Open Access License / Drug Dosage / Disclaimer
This article is licensed under the Creative Commons Attribution-NonCommercial 4.0 International License (CC BY-NC). Usage and distribution for commercial purposes requires written permission. Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug. Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.